Discontinuation report VIRAMUNE XR

Last updated on 2019-08-21 History
Report ID 92063
Drug Identification Number 02367289
Brand name VIRAMUNE XR
Common or Proper name Viramune XR
Company Name BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Market Status CANCELLED POST MARKET
Active Ingredient(s) NEVIRAPINE
Strength(s) 400MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 30's
ATC code J05AG
ATC description DIRECT ACTING ANTIVIRALS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-08-20
Remaining supply date 2019-08-20
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply no more supply
Company comments
Health Canada comments
Contact Address 5180 SOUTH SERVICE ROAD
BURLINGTON, ONTARIO
CANADA L7L 5H4
Company contact information 1800 263 2425

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2019-08-21 French Compare
v1 2019-08-21 English Compare